A detailed history of Abound Wealth Management transactions in Incyte Corp stock. As of the latest transaction made, Abound Wealth Management holds 22 shares of INCY stock, worth $1,470. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Previous 22 -0.0%
Holding current value
$1,470
Previous $1.25 Million 6.38%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Aug 08, 2024

SELL
$57.77 - $65.93 $577 - $659
-10 Reduced 31.25%
22 $1.27 Million
Q2 2023

Aug 08, 2024

BUY
$60.95 - $75.51 $609 - $755
10 Added 45.45%
32 $1.99 Million
Q1 2023

Aug 07, 2024

BUY
$70.23 - $86.01 $1,545 - $1,892
22 New
22 $1.59 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $14.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.